Protagenic Therapeutics, Inc. (PTIX) Stock Forecast
PTIX analyst forecast
as of October 21, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $4.00 average of analyst targets
- Upside to target
- +455.6% from the latest close
- Next earnings
- —
- 52-week range
- $0.13 – $3.12
PTIX analyst ratings
1 analystsNumber of analysts at each rating.
PTIX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PTIX earnings surprises
What analysts expect from PTIX
1 analysts cover Protagenic Therapeutics; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $4.00, 455.6% above the latest close of $0.72.
Related: PTIX income statement, PTIX key metrics, PTIX chart. See the PTIX stock overview for the latest quote and news.
PTIX forecast FAQ
What is Protagenic Therapeutics's price target?
The average analyst price target for Protagenic Therapeutics is $4.00, 455.6% above the latest close of $0.72.
Is Protagenic Therapeutics a buy, hold or sell?
Of 1 analysts covering Protagenic Therapeutics, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.